These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32043)

  • 1. Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.
    Ishizaki T; Tawara K
    Eur J Clin Pharmacol; 1978 Nov; 14(1):7-14. PubMed ID: 32043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1976 Feb; 19(2):148-52. PubMed ID: 4254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiac effects of timolol and propranolol.
    Achong MR; Piafsky KM; Ogilvie RI
    Clin Pharmacol Ther; 1975 Sep; 18(3):278-86. PubMed ID: 1100298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals.
    Ishizaki T; Tawara K; Oyama Y; Nakaya H
    J Clin Pharmacol; 1978; 18(11-12):511-8. PubMed ID: 721948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
    Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade.
    Wilson TW; Firor WB; Johnson GE; Holmes GI; Tsianco MC; Huber PB; Davies RO
    Clin Pharmacol Ther; 1982 Dec; 32(6):676-85. PubMed ID: 7140133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma timolol levels and systolic time intervals.
    Singh BN; Williams FM; Whitlock RM; Collett J; Chew C
    Clin Pharmacol Ther; 1980 Aug; 28(2):159-66. PubMed ID: 7398183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic differences between single and multiple oral dosing with the guidance for beta-adrenoceptor blockade assessment.
    Ishizaki T; Tawara K
    Cardiology; 1979; 64 Suppl 1():25-43. PubMed ID: 42487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the beta-adrenergic blocking agents propranolol and timolol on canine cardiac refractory periods.
    Jaillon P; Weissenburger J; Heckle J; Cheymol G
    Eur J Pharmacol; 1979 Oct; 58(3):265-71. PubMed ID: 510358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prolonged administration of propranolol and timolol on the growth and the heart of growing rabbits.
    Evemy KL; Cummins P; Littler WA
    Clin Sci (Lond); 1981 Jan; 60(1):33-40. PubMed ID: 7237922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.
    Ferguson RK; Vlasses PH; Koplin JR; Holmes GI; Huber P; Demetriades J; Abrams WB
    Br J Clin Pharmacol; 1982 Nov; 14(5):719-25. PubMed ID: 6128021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timolol maleate, a new beta-adrenergic receptor blocking agent.
    Hall RA; Robson RD; Share NN
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man.
    Miki N; Furusho Y; Itaya K; Midorikawa K; Kumagai E; Terasawa M; Ihara S; Matoba T; Toshima H
    Jpn Circ J; 1980 Oct; 44(10):783-93. PubMed ID: 6107392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E; Pickles H; Richens A
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.